Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug;8(4):2625-2630.
doi: 10.1002/ehf2.13326. Epub 2021 May 2.

Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis

Affiliations
Case Reports

Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis

Baptiste Gaudriot et al. ESC Heart Fail. 2021 Aug.

Abstract

Various clinical presentations of the 2019 coronavirus disease (COVID-19) have been described, including post-infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID-19-associated post-infectious fulminant myocarditis. Despite optimal pharmacologic management, haemodynamic status worsened requiring support by veno-arterial extracorporeal membrane oxygenation. Emergent heart transplantation was required at Day 11 given the absence of cardiac function improvement. The diagnosis of post-infectious COVID-19-associated myocarditis was made from both pathologic examination of the explanted heart and positive SARS-CoV-2 serology.

Keywords: COVID-19; Cardiogenic shock; Extracorporeal membrane oxygenation; Fulminant myocarditis; Heart transplantation.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Computed tomography (CT) pulmonary angiography. (A, B) Axial CT images (lung window: W 1600/L–500 HU) show peripheral ground‐glass opacities (white arrows) suggestive of COVID‐19 pneumonia as well as right pleural effusion (black arrow) and septal lines (white arrowheads) related to a left ventricular dysfunction. (C) CT pulmonary angiogram in the coronal plane shows no pulmonary embolism. (D) Axial post‐contrast CT image shows thickening and heterogeneous enhancement of left ventricular myocardium (black arrowheads). Note pleural and pericardial effusion.
Figure 2
Figure 2
Cardiac magnetic resonance imaging. (A, B) Four‐chamber steady‐state free precession cine images at end‐diastole (A) and end‐systole (B) demonstrate a left ventricular dysfunction (ejection fraction: 25%) with myocardial wall thickening (17 mm), as well as bilateral pleural effusion (white arrowheads). (C, D) Four‐chamber (C) and two‐chamber (D) late gadolinium enhancement images show massive and heterogeneous enhancement of the left ventricular myocardium (white arrows). Note image artefacts related to patient's tachycardia and inability to hold the breath during cardiac magnetic resonance examination.
Figure 3
Figure 3
Pathological analysis of the explanted heart. Explanted heart was first fixed in 4% formalin solution for macroscopic examination. Multiple samples were then realized (on each ventricle, apex, septum, and coronary vessels), embedded in six paraffin blocks and stained with haematoxylin–eosin–saffron before microscopic examination. Special stained were used on the more representative samples (PAS, GRAM, Grocott, Ziehl), and immunohistochemistry was also performed on 4‐μm‐thick tissue sections cut and mounted on glass slides. The preparations were dried for 1 h at 58°C and overnight at 37°C. Then the tissue sections were deparaffinized with xylene, rehydrated with ethanol, and finally pretreated and immunostained using Ventana Benchmark XT® (Ventana Roche, Switzerland). Macroscopic examination showed focal fibrinous deposits on pericardium, no valvular or coronary abnormality after dissection, but haemorrhagic suffusions in the subendocardial area. Microscopic examination demonstrated a polymorphic inflammatory infiltrate, mostly in myocardium areas but focally extended to endocardium and pericardium. Lymphocytes were predominant. Infiltrate also contained plasmocytes, neutrophils, eosinophils, and histiocytic and giant cells. Clusters of neutrophils with leucocytoclasia suggested suppurated lesions. Myocardial cells were suffering with clarified cytoplasm, sometimes fibrillary or eosinophil, and with enlarged dystrophic nucleus. Large areas of necrosis and haemorrhage were seen among these inflammatory areas. Adjacent myocardium showed interstitial oedema and focally recent interstitial fibrosis. Ziehl, Grocott, Gram, and EBER ISH stains were negative. Most of lymphocytes were T phenotype CD5+, with only a few associated B lymphocytes CD20+. Numerous histiocytic cells were revealed by CD163 immunostaining. Cytomegalovirus immunostaining was negative as well as Epstein–Barr virus in situ hybridization. A (×2) and B (×20): necrosis and polymorph inflammatory infiltrate with haematic suffusion in endocardium and myocardium. C (×10) and D (×20): pericardial inflammatory reaction.
Figure 4
Figure 4
SARS‐CoV‐2 antibodies (Ab) evolution over time. Horizontal axis shows the dates of serum samples. Left vertical axis stands for anti‐SARS‐CoV‐2‐specific immunoglobulin M (IgM), represented with black squares. Right vertical axis stands for total anti‐SARS‐CoV‐2 antibodies, represented with white circles. The vertical dashed line represents the day of heart transplantation. Serological assays following the heart transplantation should be interpreted cautiously.

References

    1. Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and proposed management of the acute COVID‐19 cardiovascular syndrome. Circulation 2020; 141: 1903–1914. - PMC - PubMed
    1. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A, Uriel N. COVID‐19 and cardiovascular disease. Circulation 2020; 141: 1648–1655. - PubMed
    1. Zheng Y‐Y, Ma Y‐T, Zhang J‐Y, Xie X. COVID‐19 and the cardiovascular system. Nat Rev Cardiol 2020; 17: 259–260. - PMC - PubMed
    1. Hékimian G, Kerneis M, Zeitouni M, Cohen‐Aubart F, Chommeloux J, Bréchot N, Mathian A, Lebreton G, Schmidt M, Hié M, Silvain J, Chambrun MP, de Haroche J, Burrel S, Marot S, Luyt C‐E, Leprince P, Amoura Z, Montalescot G, Redheuil A, Combes A. COVID‐19 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units. Chest 2020. Published online ahead of print 07 September 2020. - PMC - PubMed
    1. Centers for Disease Control and Prevention . Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID‐19). 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specim.... Accessed 11th July 2020.

Publication types